Dr. Reddy's Laboratories will ring the Closing Bell at the New York Stock Exchange (NYSE) on May 29, 2026, to celebrate 25 years of its listing. The company became the first pharmaceutical firm in Asia, outside Japan, to be listed on the NYSE in April 2001. This milestone highlights the company's long-standing presence in the global market and its commitment to governance and transparency.

The ceremony will take place at the NYSE headquarters in New York City at 4.00 pm EDT (1.30 am IST on May 30). It will be livestreamed on NYSE.com and the New York Stock Exchange YouTube channel. The event marks a significant achievement for the company, reinforcing its position as a trusted name in the U.S. market.

The senior management team, led by Chairman Satish Reddy, will participate in the ceremony. Key attendees include Erez Israeli, Chief Executive Officer; M.V. Ramana, Chief Executive Officer-Global Generics; and M.V. Narasimham, Chief Financial Officer. Independent Directors Arun M. Kumar, Penny Wan, and Sridar Iyengar (former Independent Director) will also be present.

Satish Reddy, Chairman, emphasized the significance of this milestone, stating it reaffirms the company's commitment to global governance and innovation. He noted that the vision of founder Dr. K. Anji Reddy to bring affordable medicines to patients worldwide continues to drive the company's operations.

Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, the company offers a portfolio of products and services, including APIs, generics, branded generics, biosimilars, and OTC medicines. Its major therapeutic areas include gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology.

Dr. Reddy's Laboratories witnessed a notable block trade on the National Stock Exchange (NSE), with approximately 1,462,824 shares transacted at ₹1335.70 per share. The total deal was valued at ₹195.39 crores, signaling significant institutional participation in the counter.

Block Trade Details

The following table summarizes the key parameters of the block trade recorded on the NSE:

Block trades of this scale typically indicate large institutional investors—such as mutual funds, foreign portfolio investors, or other institutional entities—executing bulk transactions outside the regular market order book. Such trades are conducted to minimize market impact while facilitating the transfer of significant share quantities between parties.